However, recent evidence indicates that chemotherapy can also act as an immune stimulant through two primary mechanisms: First, it enhances the immunogenicity and T cell infiltration of CD8 + effector T cells, which induces high expression of PD-L1 in tumor cells and promotes the presentation of TAAs on MHC Class I molecules. The gene discussed is CD8A; the disease is neoplasm.